Cover Image

Unerwünschte und erwünschte Pigmentierung = Undesirable pigmentation

BackgroundHomogenous pigmentation can be induced by α-melanocyte-stimulating hormone (MSH) homologues. Cosmetically inacceptable pigmentation is mostly located on the face.ObjectivesAlthough afamelatonide is a prescription drug for the orphan disease erthropoetic protoporphyria, structurally related...

Full description

Saved in:
Bibliographic Details
Main Author: Bayerl, Christiane (Author)
Format: Article (Journal)
Language:German
Published: October 2015
In: Der Hautarzt
Year: 2015, Volume: 66, Issue: 10, Pages: 757-763
ISSN:1432-1173
DOI:10.1007/s00105-015-3671-4
Online Access:Verlag, Volltext: http://dx.doi.org/10.1007/s00105-015-3671-4
Verlag, Volltext: https://doi.org/10.1007/s00105-015-3671-4
Get full text
Author Notes:C. Bayerl

MARC

LEADER 00000caa a2200000 c 4500
001 1585068268
003 DE-627
005 20230427161343.0
007 cr uuu---uuuuu
008 181211s2015 xx |||||o 00| ||ger c
024 7 |a 10.1007/s00105-015-3671-4  |2 doi 
035 |a (DE-627)1585068268 
035 |a (DE-576)515068268 
035 |a (DE-599)BSZ515068268 
035 |a (OCoLC)1341026985 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a ger 
084 |a 33  |2 sdnb 
100 1 |a Bayerl, Christiane  |e VerfasserIn  |0 (DE-588)1019104147  |0 (DE-627)690775083  |0 (DE-576)168366592  |4 aut 
245 1 0 |a Unerwünschte und erwünschte Pigmentierung  |b  = Undesirable pigmentation  |c C. Bayerl 
246 3 1 |a Undesirable pigmentation 
264 1 |c October 2015 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.12.2018 
520 |a BackgroundHomogenous pigmentation can be induced by α-melanocyte-stimulating hormone (MSH) homologues. Cosmetically inacceptable pigmentation is mostly located on the face.ObjectivesAlthough afamelatonide is a prescription drug for the orphan disease erthropoetic protoporphyria, structurally related α-MSH derivatives are available via the internet. Preventive and therapeutical options are necessary for postinflammatory hyperpigmentation, melasma, and lentigines.MethodsCase reports address activation of dysplastic naevi by melanotan I. Wood's lamp is of some use in analyzing the level of hyperpigmentation. However, no guidelines have been established; thus, a summary of current studies is presented.ResultsMelanotan I leads to the activation of dysplastic nevi. The gold standard for hyperpigmentation is triple therapy with hydrochinon, tretinoin, and steroids, which can cause irritation and lead to ochronosis in some individuals. Tyrosinase inhibitors, substances that increase the cell turnover, and plant derivatives are less efficient but more tolerable.ConclusionsMelanotan I and bleaching creams, which may possibly contain mercury, are dangerous. Hyperpigmentation is best treated using a combination therapy that inhibits melanocyte activity and melanin synthesis, removes melanin, destroys melanin granules, and includes UV protection. Especially in Fitzpatrick skin types IV-VI, cryotherapy and laser are not the first line treatment options due to renewed posttreatment hyperpigmentation. 
650 4 |a Camouflage 
650 4 |a Combination therapies 
650 4 |a Hyperpigmentation 
650 4 |a Hyperpigmentierung 
650 4 |a Kombinationstherapien 
650 4 |a Laser 
650 4 |a Melasma 
773 0 8 |i Enthalten in  |t Der Hautarzt  |d Berlin : Springer, 1994  |g 66(2015), 10, Seite 757-763  |h Online-Ressource  |w (DE-627)253723752  |w (DE-600)1459162-5  |w (DE-576)072372958  |x 1432-1173  |7 nnas  |a Unerwünschte und erwünschte Pigmentierung = Undesirable pigmentation 
773 1 8 |g volume:66  |g year:2015  |g number:10  |g pages:757-763  |g extent:7  |a Unerwünschte und erwünschte Pigmentierung = Undesirable pigmentation 
856 4 0 |u http://dx.doi.org/10.1007/s00105-015-3671-4  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://doi.org/10.1007/s00105-015-3671-4  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181211 
993 |a Article 
994 |a 2015 
998 |g 1019104147  |a Bayerl, Christiane  |m 1019104147:Bayerl, Christiane  |d 60000  |e 60000PB1019104147  |k 0/60000/  |p 1  |x j  |y j 
999 |a KXP-PPN1585068268  |e 3037381957 
BIB |a Y 
SER |a journal 
JSO |a {"language":["ger"],"recId":"1585068268","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 11.12.2018"],"titleTranslated":[{"translated":"Undesirable pigmentation"}],"person":[{"family":"Bayerl","given":"Christiane","roleDisplay":"VerfasserIn","display":"Bayerl, Christiane","role":"aut"}],"title":[{"title_sort":"Unerwünschte und erwünschte Pigmentierung","title":"Unerwünschte und erwünschte Pigmentierung","subtitle":" = Undesirable pigmentation"}],"relHost":[{"origin":[{"publisher":"Springer","dateIssuedDisp":"[1994?-2022]","publisherPlace":"Berlin ; Heidelberg ; New York"}],"id":{"issn":["1432-1173"],"eki":["253723752"],"zdb":["1459162-5"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Der Hautarzt","subtitle":"Organ der Deutschen Dermatologischen Gesellschaft","title_sort":"Hautarzt"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 05.07.2022","Teils ungezählte Beil.: Supplement"],"disp":"Unerwünschte und erwünschte Pigmentierung = Undesirable pigmentationDer Hautarzt","recId":"253723752","language":["ger","eng"],"corporate":[{"display":"Deutsche Dermatologische Gesellschaft","roleDisplay":"Herausgebendes Organ","role":"isb"}],"pubHistory":["Volume 45, issue 1 (January 1994) [?]-volume 73, issue 6 (June 2022)"],"part":{"extent":"7","text":"66(2015), 10, Seite 757-763","volume":"66","pages":"757-763","issue":"10","year":"2015"}}],"physDesc":[{"extent":"7 S."}],"name":{"displayForm":["C. Bayerl"]},"id":{"eki":["1585068268"],"doi":["10.1007/s00105-015-3671-4"]},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"October 2015"}]} 
SRT |a BAYERLCHRIUNERWUENSC2015 

Similar Items